Kraj P[au] - Search Results

Year	Number of Results
1995	4
1997	2
2000	1
2001	3
2002	3
2005	1
2006	1
2007	1
2008	1
2009	2
2010	1
2011	1
2013	4
2014	2
2015	4
2017	2
2018	3
2019	2
2020	2
2021	3
2022	1

1

Bone Morphogenic Protein Signaling and Melanoma.

Kraj P. Kraj P. Curr Treat Options Oncol. 2021 Apr 17;22(6):48. doi: 10.1007/s11864-021-00849-w. Curr Treat Options Oncol. 2021. PMID: 33866453 Review.

2

Bone Morphogenetic Proteins Shape T_reg Cells.

Kraj P. Kraj P. Front Immunol. 2022 Mar 28;13:865546. doi: 10.3389/fimmu.2022.865546. eCollection 2022. Front Immunol. 2022. PMID: 35418975 Free PMC article. Review.

3

The mechanisms shaping the repertoire of CD4⁺ Foxp3⁺ regulatory T cells.

Kraj P, Ignatowicz L. Kraj P, et al. Immunology. 2018 Mar;153(3):290-296. doi: 10.1111/imm.12859. Epub 2017 Nov 22. Immunology. 2018. PMID: 29106696 Free PMC article. Review.

4

Self and microbiota-derived epitopes induce CD4⁺ T cell anergy and conversion into CD4⁺Foxp3⁺ regulatory cells.

Kuczma MP, Szurek EA, Cebula A, Ngo VL, Pietrzak M, Kraj P, Denning TL, Ignatowicz L. Kuczma MP, et al. Among authors: kraj p. Mucosal Immunol. 2021 Mar;14(2):443-454. doi: 10.1038/s41385-020-00349-4. Epub 2020 Nov 2. Mucosal Immunol. 2021. PMID: 33139845 Free PMC article.

5

Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3⁺ T_reg Cells.

Browning LM, Miller C, Kuczma M, Pietrzak M, Jing Y, Rempala G, Muranski P, Ignatowicz L, Kraj P. Browning LM, et al. Among authors: kraj p. Cell Rep. 2020 Oct 6;33(1):108219. doi: 10.1016/j.celrep.2020.108219. Cell Rep. 2020. PMID: 33027660 Free PMC article.

6

Polymer Coatings on Virus-like Particle Nanoreactors at Low Ionic Strength-Charge Reversal and Substrate Access.

Kraj P, Selivanovitch E, Lee B, Douglas T. Kraj P, et al. Biomacromolecules. 2021 May 10;22(5):2107-2118. doi: 10.1021/acs.biomac.1c00208. Epub 2021 Apr 20. Biomacromolecules. 2021. PMID: 33877799 Free PMC article.

7

Bone Morphogenetic Protein Signaling Regulates Development and Activation of CD4(+) T Cells.

Kuczma M, Kraj P. Kuczma M, et al. Among authors: kraj p. Vitam Horm. 2015;99:171-93. doi: 10.1016/bs.vh.2015.05.001. Epub 2015 Jun 27. Vitam Horm. 2015. PMID: 26279376 Free PMC article. Review.

8

Dormant pathogenic CD4⁺ T cells are prevalent in the peripheral repertoire of healthy mice.

Cebula A, Kuczma M, Szurek E, Pietrzak M, Savage N, Elhefnawy WR, Rempala G, Kraj P, Ignatowicz L. Cebula A, et al. Among authors: kraj p. Nat Commun. 2019 Oct 25;10(1):4882. doi: 10.1038/s41467-019-12820-3. Nat Commun. 2019. PMID: 31653839 Free PMC article.

9

Cell-based high throughput screening identified a novel compound that promotes regulatory T cells and prevents autoimmune colitis.

Mao R, Liu H, Yi B, Purohit S, Kuczma M, Kraj P, She JX. Mao R, et al. Among authors: kraj p. Biochem Pharmacol. 2019 Nov;169:113618. doi: 10.1016/j.bcp.2019.08.020. Epub 2019 Aug 23. Biochem Pharmacol. 2019. PMID: 31449782

10

TGF-β-mediated enhancement of T_H17 cell generation is inhibited by bone morphogenetic protein receptor 1α signaling.

Browning LM, Pietrzak M, Kuczma M, Simms CP, Kurczewska A, Refugia JM, Lowery DJ, Rempala G, Gutkin D, Ignatowicz L, Muranski P, Kraj P. Browning LM, et al. Among authors: kraj p. Sci Signal. 2018 Aug 28;11(545):eaar2125. doi: 10.1126/scisignal.aar2125. Sci Signal. 2018. PMID: 30154100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results